FDA approves second gene-altering treatment for cancer – Philadelphia Business Journal
Philadelphia Business Journal |
FDA approves second gene-altering treatment for cancer
Philadelphia Business Journal The treatment, considered a form of gene therapy, transforms the patient's cells into what researchers call a “living drug” that attacks cancer cells. It is part of the rapidly growing field of immunotherapy, which uses drugs or genetic tinkering to … US approves second gene therapy against cancer |
